The association of up-regulation of X-linked inhibitor of apoptosis protein with cell adhesion-mediated drug resistance in U937 cells

Hematological Oncology

Volumn 26, Issue 1, 2008, Pages 21-26

  Wang, Xiaofang ^a   Wang, Chun ^b   Qin, You Wen ^b   Yan, Shi Ke ^b   Gao, Yan Rong ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Akt; Antisense oligonucleotides; Cell adhesion mediated drug resistance; Fibronectin; Phosphatidylinositol 3 kinase; X linked inhibitor of apoptosis protein

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTISENSE OLIGONUCLEOTIDE; DAUNORUBICIN; FIBRONECTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL STRAIN U937; CHEMOSENSITIVITY; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL ADHESION; DAUNORUBICIN; DRUG RESISTANCE, NEOPLASM; FIBRONECTINS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; U937 CELLS; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 41349090416     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.828     Document Type: Article

References (30)

1. Teicher BA, Herman TS, Holden SA, et al. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 1990; 247: 1457-1460.
2. Matsunaga T, Takemoto N, Sato T, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003; 9: 1158-1165.
3. Hazlehurst LA, Valkov N, Wisner L, et al. Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood 2001; 98: 1897-1903.
4. Damiano JS, Cress AE, Hazlehurst LA, et al. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999; 93: 1658-1667.
5. Hazlehurst LA, Damiano JS, Buyuksalm I, et al. Adhesion to fibronectin regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene 2000; 38: 4319-4327.
6. Damiano JS, Hazlehurst LA, Dalton WS, et al. Cell adhesion mediated resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma radiation. Leukemia 2001; 15: 1232-1239.
7. Hoyt DG, Rusnak JM, Mannix RJ, et al. Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells. Cancer Res 1996; 56: 4146-4149.
8. Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel- induced apoptosis in breast cancer cells. Oncogene 2001; 20: 4995-5004.
9. Sethi T, Rintoul RC, Moore SM, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999; 5: 662-5268.
10. Hanks SK, Calab MB, Harper MC, et al. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell spreading on fibronectin. Proc Natl Acad Sci 1992; 89: 8487-8491.
11. Lin TH, Aplin AE, Shen Y, et al. Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol 1997; 136: 1385-1395.
12. Meng F, Lowell CA. A β1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO J 1998; 17: 4391-4403.
13. Meredith JEJ, Fazeli B, Schwartz MA, et al. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4: 953-961.
14. Shain KH, Dalton WS. Cell Adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR. Mol Cancer Ther 2001; 1: 69-78.
15. Roy N, Deveraux QL, Takahashi R, et al. The c-IAP-1 and c-IAP-2 proteins are distinct inhibitors of specific caspases. EMBO J 1997; 16: 6914-6925.
16. Devi GR. XIAP as a target for therapeutic apoptosis in prostate cancer. Drug News Perspect 2004; 17: 127-134.
17. Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell death proteases. Nature 1997; 388: 300-304.
18. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block appropriate events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215-2223.
19. Fong WG, Liston P, Rajcan-Separovic E, et al. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70: 113-122.
20. Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancer and myeloid leukemias. Clin Cancer Res 2000; 6: 1796-1803.
21. Carter BZ, Milella M, Tsao T, et al. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia 2003; 17: 2081-2089.
22. Hu YP, Cherton-Horvat G, Dragowska V, et al. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 2003; 9: 2826-2836.
23. Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel- induced apoptosis in breast cancer cells. Oncogene 2001; 20: 4995-5004.
24. Schuetz JD, Schuetz EG. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth Differ 1993; 4: 31-40.
25. Yu R, Mandlekar S, Ruben S, et al. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Res 2000; 60: 2384-2389.
26. Voelkel-Johnson C, King DL, Norris JS. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther 2002; 9: 164-172.
27. Kumar CC. Signaling by integrin receptors. Oncogene 1998; 17: 1365-1373.
28. Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002; 115: 3729-3738.
29. Brognard J, Clark AS, Ni Y, et al. Akt/protein kinase b is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001; 61: 3986-3997.
30. Krystal GW, Sulanke G, Litz J. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol Cancer Ther 2002; 1: 913-922.